Ocular Therapeutix

Amarpreet Sawhney, PhD, President and CEO of Ocular Therapeutix shared his company’s vision: to transform the treatment of eye diseases with sustained release therapeutics. Ocular’s ReSure Sealant, the first and only FDA approved ophthalmic sealant of its kind, is a synthetic, polyethylene glycol hydrogel used to seal corneal incisions following cataract surgery. The company’s most…

Read More

Ocular Therapeutix

Amar Sawhney gives us an update on what’s going on in Ocular Therapeutix, showing us an in depth look at their product pipeline and what we can look forward to. Presenter: Amar Sawhney, PhD Amarpreet Sawhney, Ph.D., co-founded Ocular Therapeautix in 2006, has since served as President and CEO and was elected Chairman of the…

Read More

Eleven Biotherapeutics

Presenter: Abbie C. Celniker, PhD Dr. Celniker brings more than 20 years of proven protein therapeutic expertise to Eleven Biotherapeutics. Prior to joining Eleven, Abbie was CEO of Taligen Therapeutics, which was acquired by Alexion Pharmaceuticals. View Full Profile

Read More

TearScience

Presenter: Tim Willis Mr. Willis has more than 35 years of medical device industry experience. Tim is an entrepreneur and inventor and has been responsible for the development and launch of 50+ products that today represent over a half billion dollars in annual sales. View Full Profile

Read More

Eleven Biotherapeutics Gets to the Root of Ophthalmic Diseases

Eleven Biotherapeutics – Abbie Celniker, CEO for Eleven Biotherapeutics, provides the audience at the 5th Annual Ophthalmology Innovation Summit with an update on her company’s progress over the past year. Highlighting their company’s focus on understanding the biology of key targets in ophthalmic diseases and creating protein therapeutics to treat them, Abbie details the current…

Read More